Kotch, C., Barrett, D., & Teachey, D. T. (2019). Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome. Expert Rev Clin Immunol.
Styl cytowania ChicagoKotch, Chelsea, David Barrett, i David T. Teachey. "Tocilizumab for the Treatment of Chimeric Antigen Receptor T Cell-induced Cytokine Release Syndrome." Expert Rev Clin Immunol 2019.
Styl cytowania MLAKotch, Chelsea, David Barrett, i David T. Teachey. "Tocilizumab for the Treatment of Chimeric Antigen Receptor T Cell-induced Cytokine Release Syndrome." Expert Rev Clin Immunol 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..